Press "Enter" to skip to content

The simple tool that could transform surgery around the world | Carolyn Yarina | TEDxMidAtlantic


access to blood is the difference

access to blood is the difference between life and death but across the

between life and death but across the

between life and death but across the globe

globe

globe when a doctor reaches for a blood bag it

when a doctor reaches for a blood bag it

when a doctor reaches for a blood bag it often isn’t there so when a patient

often isn’t there so when a patient

often isn’t there so when a patient comes in after trauma with internal

comes in after trauma with internal

comes in after trauma with internal bleeding what can that doctor do well

bleeding what can that doctor do well

bleeding what can that doctor do well there is one option and often the only

there is one option and often the only

there is one option and often the only option is actually to salvage and

option is actually to salvage and

option is actually to salvage and recycle that person’s own blood through

recycle that person’s own blood through

recycle that person’s own blood through a process called Auto transfusion in

a process called Auto transfusion in

a process called Auto transfusion in this process Johns Hopkins University

this process Johns Hopkins University

this process Johns Hopkins University has actually been showing is better than

has actually been showing is better than

has actually been showing is better than using donor blood because your own blood

using donor blood because your own blood

using donor blood because your own blood is better and as donor blood sits on the

is better and as donor blood sits on the

is better and as donor blood sits on the shelf it loses its ability to transport

shelf it loses its ability to transport

shelf it loses its ability to transport oxygen and nutrients and also there’s a

oxygen and nutrients and also there’s a

oxygen and nutrients and also there’s a risk of disease transfer there’s a risk

risk of disease transfer there’s a risk

risk of disease transfer there’s a risk of rejection and you know what we

of rejection and you know what we

of rejection and you know what we actually do this process in the United

actually do this process in the United

actually do this process in the United States but the technology we use to do

States but the technology we use to do

States but the technology we use to do so looks like this it’s unsuitable in

so looks like this it’s unsuitable in

so looks like this it’s unsuitable in emerging markets due to high cost

emerging markets due to high cost

emerging markets due to high cost training and power requirements so this

training and power requirements so this

training and power requirements so this technology is not reaching a lot of the

technology is not reaching a lot of the

technology is not reaching a lot of the world but I am in awe of doctors around

world but I am in awe of doctors around

world but I am in awe of doctors around the globe who are using the tools that

the globe who are using the tools that

the globe who are using the tools that they have not medical devices but simple

they have not medical devices but simple

they have not medical devices but simple techniques to do this process they’re

techniques to do this process they’re

techniques to do this process they’re literally sometimes using a cup or a

literally sometimes using a cup or a

literally sometimes using a cup or a soup ladle to scoop blood out from

soup ladle to scoop blood out from

soup ladle to scoop blood out from internal bleeding filter it through

internal bleeding filter it through

internal bleeding filter it through gauze Andry transfuse it back to that

gauze Andry transfuse it back to that

gauze Andry transfuse it back to that same person question that’s been in my

same person question that’s been in my

same person question that’s been in my mind when I first saw this was why why

mind when I first saw this was why why

mind when I first saw this was why why is this and you might think that this

is this and you might think that this

is this and you might think that this procedure is done in sub-saharan Africa

procedure is done in sub-saharan Africa

procedure is done in sub-saharan Africa so one reason is that you know maybe

so one reason is that you know maybe

so one reason is that you know maybe there’s no money there but when you dive

there’s no money there but when you dive

there’s no money there but when you dive in a little bit further you recognize

in a little bit further you recognize

in a little bit further you recognize that you know what each bag of donor

that you know what each bag of donor

that you know what each bag of donor blood just the cost of the disease

blood just the cost of the disease

blood just the cost of the disease testing and the infrastructure costs

testing and the infrastructure costs

testing and the infrastructure costs $100 per blood bag and in the u.s.

$100 per blood bag and in the u.s.

$100 per blood bag and in the u.s. that’s $250

that’s $250

that’s $250 so that’s not it and if you take even a

so that’s not it and if you take even a

so that’s not it and if you take even a step back and look at the overall system

step back and look at the overall system

step back and look at the overall system of medical devices and design well

of medical devices and design well

of medical devices and design well actually right now 80% of the world’s

actually right now 80% of the world’s

actually right now 80% of the world’s medical devices are designed for 10% of

medical devices are designed for 10% of

medical devices are designed for 10% of the world’s population what does that

the world’s population what does that

the world’s population what does that mean that means that medical devices are

mean that means that medical devices are

mean that means that medical devices are being designed for the Western world but

being designed for the Western world but

being designed for the Western world but not for the rest of the world so I

not for the rest of the world so I

not for the rest of the world so I started working on this a little over

started working on this a little over

started working on this a little over six years ago I founded a non-profit

six years ago I founded a non-profit

six years ago I founded a non-profit working with rural mobile clinics in

working with rural mobile clinics in

working with rural mobile clinics in India and I started thinking about this

India and I started thinking about this

India and I started thinking about this challenge and working with these doctors

challenge and working with these doctors

challenge and working with these doctors to design medical devices through this

to design medical devices through this

to design medical devices through this nonprofit and I saw there really three

nonprofit and I saw there really three

nonprofit and I saw there really three ways that medical devices were reaching

ways that medical devices were reaching

ways that medical devices were reaching emerging markets and the first that you

emerging markets and the first that you

emerging markets and the first that you might have heard about before is

might have heard about before is

might have heard about before is donating medical equipment but you know

donating medical equipment but you know

donating medical equipment but you know what a lot of this equipment ended up in

what a lot of this equipment ended up in

what a lot of this equipment ended up in what’s called over there medical device

what’s called over there medical device

what’s called over there medical device graveyards because it doesn’t function

graveyards because it doesn’t function

graveyards because it doesn’t function for something as simple as there’s a

for something as simple as there’s a

for something as simple as there’s a diagnostic equipment where there’s a

diagnostic equipment where there’s a

diagnostic equipment where there’s a roll of paper you print the results on

roll of paper you print the results on

roll of paper you print the results on if that paper isn’t there to print the

if that paper isn’t there to print the

if that paper isn’t there to print the results the equipment doesn’t work so

results the equipment doesn’t work so

results the equipment doesn’t work so you need the supply chain so then well

you need the supply chain so then well

you need the supply chain so then well large medical device companies are also

large medical device companies are also

large medical device companies are also trying to enter into emerging markets

trying to enter into emerging markets

trying to enter into emerging markets they recognize the opportunity there

they recognize the opportunity there

they recognize the opportunity there because well medical devices in emerging

because well medical devices in emerging

because well medical devices in emerging markets are 64 billion dollar industry

markets are 64 billion dollar industry

markets are 64 billion dollar industry and it’s growing at over five times the

and it’s growing at over five times the

and it’s growing at over five times the rate of Western markets like the United

rate of Western markets like the United

rate of Western markets like the United States but what they’re doing is they’re

States but what they’re doing is they’re

States but what they’re doing is they’re taking Western equipment paring off

taking Western equipment paring off

taking Western equipment paring off features making it cheaper and they

features making it cheaper and they

features making it cheaper and they think that’s gonna sell and it’s not

think that’s gonna sell and it’s not

think that’s gonna sell and it’s not working there’s these huge gaps in

working there’s these huge gaps in

working there’s these huge gaps in technology because the requirements in

technology because the requirements in

technology because the requirements in the needs and the way money is spent is

the needs and the way money is spent is

the needs and the way money is spent is just different and so nonprofits as well

just different and so nonprofits as well

just different and so nonprofits as well are targeting this so even my own prior

are targeting this so even my own prior

are targeting this so even my own prior company but as I found out first hand

company but as I found out first hand

company but as I found out first hand building and getting the capital to

building and getting the capital to

building and getting the capital to create an R&D regulated intensive

create an R&D regulated intensive

create an R&D regulated intensive product is really hard as a nonprofit

product is really hard as a nonprofit

product is really hard as a nonprofit and if you can get through that barrier

and if you can get through that barrier

and if you can get through that barrier there’s also no focus on really

there’s also no focus on really

there’s also no focus on really commercializing and scaling those

commercializing and scaling those

commercializing and scaling those in a way that incentivized the entire

in a way that incentivized the entire

in a way that incentivized the entire supply chain so that’s what I’ve been

supply chain so that’s what I’ve been

supply chain so that’s what I’ve been working on and two and a half years ago

working on and two and a half years ago

working on and two and a half years ago created a company to address this very

created a company to address this very

created a company to address this very issue of not only design but

issue of not only design but

issue of not only design but commercialization and we decided to

commercialization and we decided to

commercialization and we decided to start with a very simple challenge and

start with a very simple challenge and

start with a very simple challenge and just one challenge to start one device

just one challenge to start one device

just one challenge to start one device to prove this system that we will then

to prove this system that we will then

to prove this system that we will then pull other products in and that’s a

pull other products in and that’s a

pull other products in and that’s a product we call Hema fuse so I mentioned

product we call Hema fuse so I mentioned

product we call Hema fuse so I mentioned that access to blood and how that can be

that access to blood and how that can be

that access to blood and how that can be solved by a very simple technology and

solved by a very simple technology and

solved by a very simple technology and that’s what we’ve created so this is the

that’s what we’ve created so this is the

that’s what we’ve created so this is the device that combines the safety

device that combines the safety

device that combines the safety standards that we see in the United

standards that we see in the United

standards that we see in the United States for auto transfusion with

States for auto transfusion with

States for auto transfusion with innovation and simplicity of what’s

innovation and simplicity of what’s

innovation and simplicity of what’s being done in emerging markets and how

being done in emerging markets and how

being done in emerging markets and how it functions is simply you pull the

it functions is simply you pull the

it functions is simply you pull the handle up blood is pulled in through a

handle up blood is pulled in through a

handle up blood is pulled in through a filter from internal bleeding and you

filter from internal bleeding and you

filter from internal bleeding and you press the handle down and it’s

press the handle down and it’s

press the handle down and it’s transferred directly to a blood bag to

transferred directly to a blood bag to

transferred directly to a blood bag to be retransferred

be retransferred

be retransferred and this technology it’s not a small

and this technology it’s not a small

and this technology it’s not a small problem across sub-saharan Africa there

problem across sub-saharan Africa there

problem across sub-saharan Africa there are 20 million cases each year that are

are 20 million cases each year that are

are 20 million cases each year that are viable for this process and as these ago

viable for this process and as these ago

viable for this process and as these ago we recognized that opportunity and we

we recognized that opportunity and we

we recognized that opportunity and we also see the commercial application

also see the commercial application

also see the commercial application where we can create value for ourselves

where we can create value for ourselves

where we can create value for ourselves as a for-profit entity create value for

as a for-profit entity create value for

as a for-profit entity create value for the distributor who will scale the

the distributor who will scale the

the distributor who will scale the product and for the hospital because

product and for the hospital because

product and for the hospital because they are business as well doing business

they are business as well doing business

they are business as well doing business of saving people’s lives and at the very

of saving people’s lives and at the very

of saving people’s lives and at the very end keeping the patient in mind and

end keeping the patient in mind and

end keeping the patient in mind and having our device equal the cost of one

having our device equal the cost of one

having our device equal the cost of one unit of donor blood and save them on

unit of donor blood and save them on

unit of donor blood and save them on average 100 dollars out-of-pocket

average 100 dollars out-of-pocket

average 100 dollars out-of-pocket because our device can salvage as many

because our device can salvage as many

because our device can salvage as many pints as are pulling internally and

pints as are pulling internally and

pints as are pulling internally and we’re doing this right now we have

we’re doing this right now we have

we’re doing this right now we have proven the technical viability of our

proven the technical viability of our

proven the technical viability of our products we’ve done testing with blood

products we’ve done testing with blood

products we’ve done testing with blood we’ve done usability studies across

we’ve done usability studies across

we’ve done usability studies across Africa and the device is actually in use

Africa and the device is actually in use

Africa and the device is actually in use for the very first time in Ethiopia

for the very first time in Ethiopia

for the very first time in Ethiopia right now and really we’re very close

right now and really we’re very close

right now and really we’re very close commercializing the product thank you so

commercializing the product thank you so

commercializing the product thank you so we see something much more than this

we see something much more than this

we see something much more than this something much more than this device and

something much more than this device and

something much more than this device and actually a pipeline to take medical

actually a pipeline to take medical

actually a pipeline to take medical devices out into emerging markets that

devices out into emerging markets that

devices out into emerging markets that are designed with and for these doctors

are designed with and for these doctors

are designed with and for these doctors and emerging markets and what I want to

and emerging markets and what I want to

and emerging markets and what I want to leave you is I’m often asked why why me

leave you is I’m often asked why why me

leave you is I’m often asked why why me why this why now and for me I go back to

why this why now and for me I go back to

why this why now and for me I go back to that first device

that first device

that first device I took over to India with my nonprofit

I took over to India with my nonprofit

I took over to India with my nonprofit and was told by doctors who had never

and was told by doctors who had never

and was told by doctors who had never had a device designed with them or for

had a device designed with them or for

had a device designed with them or for them that this product could save lives

them that this product could save lives

them that this product could save lives but really I think the more important

but really I think the more important

but really I think the more important question of is not just why not just why

question of is not just why not just why

question of is not just why not just why look at medical devices and emerging

look at medical devices and emerging

look at medical devices and emerging markets and how fast they’re growing and

markets and how fast they’re growing and

markets and how fast they’re growing and the opportunity there and the

the opportunity there and the

the opportunity there and the opportunity to save lives but really ask

opportunity to save lives but really ask

opportunity to save lives but really ask why not why not change the discussion

why not why not change the discussion

why not why not change the discussion why not get these technologies out into

why not get these technologies out into

why not get these technologies out into the hands of those doctors so they can

the hands of those doctors so they can

the hands of those doctors so they can save lives with proper tools to do so

save lives with proper tools to do so

save lives with proper tools to do so and I challenge all of you to think the

and I challenge all of you to think the

and I challenge all of you to think the same way so if you hear in a sentence

same way so if you hear in a sentence

same way so if you hear in a sentence both medical devices and sub-saharan

both medical devices and sub-saharan

both medical devices and sub-saharan Africa ask why not thank you

Africa ask why not thank you

Africa ask why not thank you [Applause]

”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *